Clinical Trial

A Study to Evaluate Microneedle-based Collection of Dermal Interstitial Skin Fluid in Healthy Participants and Atopic Dermatitis Participants

Completed
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate microneedle-based collection of dermal interstitial skin fluid (dISF) in healthy participants and atopic dermatitis (AD) participants
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-04-11; most recent amendment 2026-01-15.
Status change: Recruiting → Completed 2026-01-15
Status change: Not Yet Recruiting → Recruiting 2025-07-09
Trial Details
NCT Number NCT06934980
Lead Sponsor Incyte Corporation
Conditions Atopic Dermatitis, Healthy Volunteers
Enrollment 20 participants
Start Date 2025-06-27
Primary Completion 2025-12-19 (estimated)
Study Completion 2025-12-19 (estimated)
Updated on ClinicalTrials.gov 2026-01-16